Effectiveness of Neuromuscular Electrical Stimulation Added to Oral Motor Therapy in Children With Cerebral Palsy Experiencing Drooling Problems: A Randomized Controlled Trial
| Registry | NCT07069257, acronym NOMES-CP |
|---|---|
| Status | Not yet recruiting |
| Phase | Not applicable |
| Study type | Interventional; randomized, parallel, masking: double, treatment |
| Enrollment | 30 (Estimated) |
| Sponsor | Aslinur Keles Ercisli, MD, PhD (Other); collaborators: Fatih Sultan Mehmet Training and Research Hospital |
| Conditions | Cerebral Palsy (CP), Drooling |
| Interventions | Oral Motor Therapy, Neuromuscular Electrical Stimulation (NMES), Sham Neuromuscular Electrical Stimulation (Sham NMES) (Behavioral, device) |
| Dates | start 2026-05-01 (estimated), primary completion 2026-07-01 (estimated), completion 2026-08-01 (estimated), first posted 2025-07-16, last updated 2026-04-15 |
| Locations | 1 site in Turkey (Türkiye) |
Related Papers Related Patents Related Grants Related Experts
All trials for Cerebral Palsy (CP) All trials for Drooling All trials of Oral Motor Therapy All trials of Neuromuscular Electrical Stimulation (NMES)
This randomized, controlled, single-blind trial aims to investigate the effectiveness of neuromuscular electrical stimulation (NMES) combined with oral motor therapy in reducing drooling severity among children with cerebral palsy. Participants will be allocated to an intervention group (oral motor therapy plus NMES), a control group (oral motor therapy alone) and a sham group (oral motor therapy with placebo NMES).
Drooling is a common and disabling problem in children with cerebral palsy, adversely affecting health, social participation, and quality of life. Oral motor therapy is frequently used to improve oral control, and neuromuscular electrical stimulation (NMES) has been suggested as an adjunctive treatment to enhance orofacial muscle function.
This randomized, controlled, single-blind study will include children aged 4 to 17 years diagnosed with cerebral palsy and presenting with moderate to severe drooling (Drooling Severity and Frequency Scale score ≥3). Participants will be randomly assigned to one of three groups: oral motor therapy alone, oral motor therapy plus active NMES, and oral motor therapy with sham NMES. The intervention comprises twelve therapy sessions over four weeks, delivered by a trained therapist.
Oral motor therapy involves exercises targeting lips, tongue, cheeks, and jaw, in addition to thermal and tactile stimulation (using brushes, spoons, cold packs, and heat packs). NMES will be applied bilaterally to the masseter muscles and to the orbicularis oris muscle using a Chattanooga NMES device. Sham NMES will simulate the procedure without delivering active stimulation.
Outcome measures will be assessed before and after the intervention and will include both subjective and objective drooling scales: Drooling Severity and Frequency Scale (DSFS), Drooling Impact Scale (DIS), Visual Analog Scale for drooling severity, Drooling Quotient (DQ5), and caregiver reports of bib usage. Orofacial muscle thickness will be measured with ultrasound imaging. Additional assessments will include functional classification systems (GMFCS, MACS, CFCS, VFCS, EDACS, FOIS) and the Pediatric Eating Assessment Tool (PEDI EAT-10).
This study is approved by the Ethics Committee of Istanbul Medipol University.
| Arm | Type | Interventions | Description |
|---|---|---|---|
| Oral Motor Therapy Plus NMES | Experimental | Behavioral: Oral Motor Therapy; Device: Neuromuscular Electrical Stimulation (NMES) | Participants assigned to this arm will receive oral motor therapy combined with active neuromuscular electrical stimulation (NMES) applied to the masseter and orbicularis oris muscles. |
| Oral Motor Therapy | Other | Behavioral: Oral Motor Therapy | Participants assigned to this arm will receive oral motor therapy without any NMES. This is a behavioral therapy. |
| Oral Motor Therapy Plus Sham NMES | Sham comparator | Behavioral: Oral Motor Therapy; Device: Sham Neuromuscular Electrical Stimulation (Sham NMES) | Participants assigned to this arm will receive oral motor therapy combined with sham NMES that does not deliver active stimulation. |
Sex: All, ages: 4 Years to 17 Years
Inclusion Criteria: * Diagnosis of cerebral palsy (unilateral/bilateral spastic, ataxic, dyskinetic, or mixed type) * Presence of drooling control problems * Age between 4 and 17 years * Gross Motor Function Classification System (GMFCS) levels 2, 3, 4, or 5 * Stable drooling severity for at least one month prior to enrollment * Drooling Severity and Frequency Scale (DSFS) score of 3 or higher Exclusion Criteria: * Diagnosis of dysphagia * Use of medications affecting drooling within the past 72 hours * Upper respiratory tract infection and/or salivary gland infection during the study period * History of botulinum toxin injection to the salivary glands
| Facility | City | Country | Status |
|---|---|---|---|
| Fatih Sultan Mehmet Training and Research Hospital | Ataşehir, Istanbul | Turkey (Türkiye) |